NCT05715203

Brief Summary

The goal of this observational study is to study arterial stiffness in patients with thoracic ascending aortic aneurysms (TAA), either syndromic or non-syndromic. The main questions it aims to answer are:

  • Stratification of aortic risk based on arterial stiffness; Compare measurements with morphological and haemodynamic features of the ascending thoracic aorta. Participants will be asked to undergo non-invasive evaluation of blood pressure and arterial stiffness.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
250

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 27, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

February 6, 2023

Completed
9 days until next milestone

Study Start

First participant enrolled

February 15, 2023

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

September 10, 2025

Status Verified

July 1, 2025

Enrollment Period

2.8 years

First QC Date

January 27, 2023

Last Update Submit

September 8, 2025

Conditions

Keywords

arterial stiffnessAscending aortic aneurysmpulse wave velocity

Outcome Measures

Primary Outcomes (1)

  • Pulse Wave Velocity

    Statistic analysis will be performed using the Statistical Package for Social Science (SPSS for Windows; v20.0; SPSS, Chicago, Illinois, USA). Continuous variables will be expressed as mean ± Standard Deviation, while qualitative variables will be expressed as a percentage. Qualitative data will be compared using Fisher's test or Pearson's χ2 test, when appropriate. Continuous variables by t-test or analysis of variance normalized for covariates. Continuous variables will be correlated by simple or multiple linear regression

    18 months

Study Arms (2)

Syndromic TAA

Subjets with clinical or genetic diagnosis of syndromic thoracic aortic aneurysms

Device: Pulsotonometry

Non-syndromic TAA

Subjets without clinical or genetic diagnosis of syndromic thoracic aortic aneurysms

Device: Pulsotonometry

Interventions

Evaluation of arterial stiffness

Non-syndromic TAASyndromic TAA

Eligibility Criteria

Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with ascending aortic aneurysms currently in follow.up at Cardiovascular Gentic Centre, IRCCS Policlinico San Donato.

You may qualify if:

  • Subjects with AAT, either syndromic or non syndromic;
  • Signed informed consent

You may not qualify if:

  • Patients with early menopause and/or osteoporosis, rheumatic heart disease and active malignant tumours;
  • Patients with acute and chronic inflammatory conditions such as: chronic liver disease, chronic renal insufficiency and diseases affecting the thyroid system;
  • Seropositivity to HIV, HCV, HBsAg and SARS-CoV-2;
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS Policlinico San Donato

San Donato Milanese, Lombardy, 20097, Italy

RECRUITING

MeSH Terms

Conditions

Rare DiseasesAneurysm, Ascending Aorta

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsAortic Aneurysm, ThoracicAortic AneurysmAneurysmVascular DiseasesCardiovascular DiseasesAortic Diseases

Study Officials

  • Alessandro Pini

    Cardiovascular-Gentic Centre, IRCCS Policlinico San Donato

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 27, 2023

First Posted

February 6, 2023

Study Start

February 15, 2023

Primary Completion

November 30, 2025

Study Completion

December 31, 2025

Last Updated

September 10, 2025

Record last verified: 2025-07

Locations